if we continue this bear reversal in biotech labd may cross signal and estimate bull and reach for upper envelope in a reverse head and shouldern pattern. if we carve a path higher in major indices i expect biotech to follow.
Hi again, I see that you are back near buy point.
I'll buy if the price breaks above this range at $31.50 and add more once breaks to a new all time high at $34.
The stock highly volatile, so I suggest starting with small positions and/or staggered stops.
prepared for different scenarios but overall continuing bear for biotech. this sector is going to get hit hard from annual plans for labs, and whether we hit top of envelope first or revisit bottom sooner were still in an overall end of bullish corrective phase from bear market leaving lows open for test.
this is a top gainer today that could still go either way. if we stay above retracement we could reach for daily highs and beyond. maybe high 26s. much more likely is diving back below envelope and retesting signal, estimate, bottom of envelope around the .5 retrace.
*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals announced a shelf offering of $10 million today. This...
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor...
Both $QQQ and $XBI made a bullish reversal open on 27 Sep., however QQQ sold down while XBI moved higher.
When the daily candle on XBI (or candle pattern) does not match that on QQQ, take note. I have added lines to highlight examples, and these mismatches often occur at turning points with XBI indicating direction for QQQ.
It is not a sure predictor, as you can...
LABU a 3x leveraged EFT in the biotechnology sector has diverse holdings.
My thesis is that biotechnology and healthcare are relatively unhinged from the broader general market.
On this 15 minute chart, consolidation at support is seen in July, Price then rapidly rose
into a triple top in mid-August followed by a descent into a double bottom at...
Catalyst Pharma (CPRX) is an absolute monster. Not only is the company posting huge sales and earnings growth in a sector that rarely has either, the stock has more than doubled over the last few months.
There are 801 stocks in the biotech group tracked by Investors Business Daily, and CPRX ranks at the very top (see image in chart).
After such a large advance...
NBIX is in the biotech sector which I have been highlighting for several months as one of the strongest areas in the market.
After emerging from a textbook breakout pattern in early August, shares have consolidated in a tight handle formation.
If you look at the relative strength line at the top of the chart, you will notice three pink dots over the last several...